Offer An Article

Pandemic Latest News

National

Pharma prices may be linked to per capita GDP

In a move sure to upset people worldwide, India has announced that it may introduce a system  of price controls for patented medicines. Here’s the story in today’s Economic Times. The principle would be that the Indian cap would be based on the price that government pays in Australia, Canada, France and the UK. So far, …

Pharma prices may be linked to per capita GDP Read More »

President calls for a second freedom struggle against disease, hunger and poverty

India’s new President has called for a “‘second freedom struggle’ to eradicate hunger, disease and poverty,” according to Outlook, the weekly news magazine. Pranab Mukherjee was speaking on the eve of the 65th anniversary of India’s independence. The reference is to the struggle for freedom over more than fifty years leading up to independence. The …

President calls for a second freedom struggle against disease, hunger and poverty Read More »

India universal health plans not as promised?

In today’s Hindu, activists say that the Planning Commission is breaking promises to increase health spending in India closer to normal levels for middle-income countries. The activists also say that the Cetre is trying to shift costs to the states.  The future role of the corporate sector in insurance-based managed care plans is, predictably, extremely …

India universal health plans not as promised? Read More »

Government free medicine scheme starts this year

This very uncritical Times of India piece reports on the October start of the government free medicines scheme (even more noteworthy as the ToI is not known for being uncritical of the government). The article does list all of the pitfalls of separate lists in every state and the need for state contributions. It also …

Government free medicine scheme starts this year Read More »

Access to cancer treatment in India — everyone’s to blame

This piece on the Spicy IP blog is by a young patent law expert who now has family experience of the problems of cancer treatment in India. It is a thoughtful and well written piece which argues that innovative pharma companies, generics companies, state governments, Central government and insured individuals must all take some of …

Access to cancer treatment in India — everyone’s to blame Read More »